The Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome

Simple item page
dc.contributor.authorO'Brien, Rebecca
dc.contributor.authorO'Malley, Dervla
dc.contributor.funderUniversity College Corken
dc.date.accessioned2019-11-08T12:54:49Z
dc.date.available2019-11-08T12:54:49Z
dc.date.issued2019-10-11
dc.date.updated2019-11-08T12:43:33Z
dc.description.abstractBackground: Glucagon-like peptide-1 (GLP-1) is beneficial in relieving pain-related symptoms of Irritable bowel syndrome (IBS), a prevalent, multi-factorial functional bowel disorder characterized by diarrhea and/or constipation, abdominal bloating, and pain. Activation of myenteric neurons has been implicated in the inhibitory effects of GLP-1 on gastrointestinal motility; however, the mechanisms of action underlying this are not clear. Methods: A rat model of IBS was used to examine physiological changes evoked by intraperitoneal administration of a GLP-1 receptor agonist, exendin-4. Behavioral and physiological analysis of stress-sensitive Wister Kyoto (WKY) rats was used to determine if administration of exendin-4, in the presence or absence of neutralizing interleukin-6 receptor monoclonal antibodies, modified IBS-like symptoms. Immunofluorescence, calcium imaging, and Western blotting techniques were used to investigate the potential role of enteric neural plexi and tight junction protein expression in this effect. Key Results: Consistent with the expression of GLP-1 and interleukin-6 receptors in both submucosal and myenteric ganglia, exendin-4 and interleukin-6 stimulated calcium responses in these neurons. In vivo administration of exendin-4 normalized stress-induced defecation and visceral pain sensitivity in WKY rats. No additional changes were noted in rats co-treated with exendin-4 and anti-interleukin-6 receptor antibodies. Mucosal expression of occludin, a tight junction protein, was decreased by exendin-4. Centrally regulated anxiety-like behaviors were not modified. Conclusions and Inferences: These data suggest that intraperitoneal injection of exendin-4 improves bowel dysfunction in WKY rats without impacting on centrally regulated anxiety-like behaviors. Modulation of enteric neuronal function and tight junction expression appear to underlie the functional benefits of this intervention.en
dc.description.sponsorshipUniversity College Cork (School of Medicine TRAP funding)en
dc.description.statusPeer revieweden
dc.description.versionAccepted Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleide13738en
dc.identifier.citationO'Brien, R. and O'Malley, D. (2019) 'The Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome', Neurogastroenterology and Motility. doi: 10.1111/nmo.13738en
dc.identifier.doi10.1111/nmo.13738en
dc.identifier.eissn1365-2982
dc.identifier.issn1350-1925
dc.identifier.journaltitleNeurogastroenterology and Motilityen
dc.identifier.urihttps://hdl.handle.net/10468/8980
dc.language.isoenen
dc.publisherJohn Wiley & Sons Ltd.en
dc.relation.urihttps://onlinelibrary.wiley.com/doi/abs/10.1111/nmo.13738
dc.rights© 2019, John Wiley & Sons Ltd. This is the peer reviewed version of the following article: O'Brien, R. and O'Malley, D. (2019) 'The Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome', Neurogastroenterology and Motility, doi: 10.1111/nmo.13738, which has been published in final form at https://doi.org/10.1111/nmo.13738. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.en
dc.subjectColorectal distensionen
dc.subjectOpen fielden
dc.subjectStressen
dc.subjectWister Kyotoen
dc.subjectExendin‐4en
dc.subjectGlucagon‐like peptide‐1en
dc.subjectInterleukin‐6en
dc.titleThe Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndromeen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
O'Brien_NGM_WKY_Ex-4_2019_incl_figs.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format
Description:
Accepted Version
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Physiology - Journal Articles
APC Microbiome Ireland - Journal Articles